BRIM Biotechnology, Inc. (TPE:6885)
25.85
-0.25 (-0.96%)
At close: Mar 6, 2026
BRIM Biotechnology Revenue
BRIM Biotechnology had revenue of 1.23M TWD in the quarter ending September 30, 2025, with 1,762.12% growth. This brings the company's revenue in the last twelve months to 3.17M, up 1,933.33% year-over-year. In the year 2024, BRIM Biotechnology had annual revenue of 333.00K with 270.00% growth.
Revenue (ttm)
3.17M
Revenue Growth
+1,933.33%
P/S Ratio
1,045.72
Revenue / Employee
99.13K
Employees
32
Market Cap
3.32B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Intech Biopharm | 113.85M |
| Sagittarius Life Science | 424.44M |
| SYN-TECH Chem. & Pharm. | 1.30B |
| ACRO Biomedical | 36.50M |
| Syngen Biotech | 2.14B |
| 3D Global Biotech | 324.87M |
| Genovate Biotechnology | 492.41M |
| Apex Biotechnology | 1.96B |